South San Francisco ultrafast CT developer Imatron last month reported less than stellar results for 1998 (end-December). The company saw revenues of $30.7 million from the sale of 15 scanners, down 18% compared with last year’s $37.3 million on
South San Francisco ultrafast CT developer Imatron last month reported less than stellar results for 1998 (end-December). The company saw revenues of $30.7 million from the sale of 15 scanners, down 18% compared with last years $37.3 million on sales of 18 scanners. Imatron posted a net loss of $14.8 million, compared with a net loss of $11.4 million the previous year.
The firms results were affected by the continuing financial turmoil in Asia, traditionally a strong market for ultrafast CT. Imatron was also hit by its inability to sell ultrafast CT scanners itself in the U.S. and Europe during the first quarter of 1998 because Siemens was its exclusive distributor during that period. The company did best in the U.S., where it sold nine of the 15 scanners for the year.
In other Imatron news, an Associated Press article published on March 27 cited research claiming that conventional mechanical CT scanners with electrocardiogram gating can detect coronary calcification just as well as Imatrons electron beam CT systems. The research was presented at a medical conference in Orlando, FL, sponsored by the American Heart Association, and was covered in several other sources, including The New York Times.
In addition, the company this month formed an alliance with its Japanese distributor, Imatron-Japan, and Japanese general trading company Marubeni to market Ultrafast CT in the Japanese market. Marubeni will provide capital to finance purchases of the scanners and has already assisted in two sales.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.